| Date Filed | Type | Description |
| 02/24/2023 |
4
| SCARLETT JOHN A (Chairman, President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 1,750,000 options to buy
@ $2.83, valued at
$5M
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| SCARLETT JOHN A (Chairman, President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 2,100,000 options to buy
@ $1.06, valued at
$2.2M
|
|
| 08/05/2021 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CHIASMA, INC|
Txns:
| Disposed/sold 61,322 shares
@ $0
Disposed/sold 10,000 options to buy
@ $3.14, valued at
$31.4k
Disposed/sold 13,000 options to buy
@ $1.35, valued at
$17.6k
Disposed/sold 13,000 options to buy
@ $1.45, valued at
$18.9k
Disposed/sold 13,000 options to buy
@ $7.98, valued at
$103.7k
Disposed/sold 13,000 options to buy
@ $5.81, valued at
$75.5k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.35, valued at
$167k
|
|
| 06/12/2020 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CHIASMA, INC|
Txns:
| Granted 13,000 options to buy
@ $5.81, valued at
$75.5k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $11.31, valued at
$158.3k
|
|
| 06/17/2019 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CHIASMA, INC|
Txns:
| Granted 13,000 options to buy
@ $7.98, valued at
$103.7k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2018 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $25.25, valued at
$353.5k
|
|
| 06/11/2018 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CHIASMA, INC|
Txns:
| Granted 13,000 options to buy
@ $1.45, valued at
$18.9k
|
|
| 02/02/2018 |
4
| SCARLETT JOHN A (President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 1,050,000 options to buy
@ $2.45, valued at
$2.6M
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2016 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 28,000 options to buy
@ $10.17, valued at
$284.8k
|
|
| 06/13/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/13/2016 |
4
| SCARLETT JOHN A (Director) has filed a Form 4 on CHIASMA, INC|
Txns:
| Granted 10,000 options to buy
@ $3.14, valued at
$31.4k
|
|
| 02/12/2016 |
4
| SCARLETT JOHN A (President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 600,000 options to buy
@ $2.54, valued at
$1.5M
|
|
| 03/16/2015 |
4
| SCARLETT JOHN A (President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 600,000 options to buy
@ $4.34, valued at
$2.6M
|
|
| 02/12/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/01/2013 |
4
| SCARLETT JOHN A (President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Bought 50,000 shares
@ $1.03, valued at
$51.5k
|
|
| 02/14/2013 |
4
| SCARLETT JOHN A (President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 1,340,000 options to buy
@ $1.5, valued at
$2M
|
|
| 05/18/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2012 |
4
| SCARLETT JOHN A (President and CEO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 75,000 shares
@ $1.72, valued at
$129k
|
|
| 10/03/2011 |
3
| SCARLETT JOHN A (CEO) has filed a Form 3 on GERON CORP |